Pana Tiberiu A, Wood Adrian D, Perdomo-Lampignano Jesus A, Tiamkao Somsak, Clark Allan B, Kongbunkiat Kannikar, Bettencourt-Silva Joao H, Sawanyawisuth Kittisak, Kasemsap Narongrit, Mamas Mamas A, Myint Phyo K
Ageing Clinical and Experimental Research Team, Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
Neurology Division, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Heart Asia. 2019 Apr 20;11(1):e011139. doi: 10.1136/heartasia-2018-011139. eCollection 2019.
We aimed to examine the impact of heart failure (HF) on stroke mortality (in-hospital and postdischarge) and recurrence in a national stroke cohort from Thailand.
We used a large, insurance-based database including all stroke admissions in the public health sector in Thailand between 2004 and 2015. Logistic and Royston-Parmar regressions were used to quantify the effect of HF on in-hospital and long-term outcomes, respectively. All models were adjusted for age, sex and comorbidities and stratified by stroke type: acute ischaemic stroke (AIS) or intracerebral haemorrhage (ICH). Multistate models were constructed using flexible survival techniques to predict the impact of HF on the disease course of a patient with stroke (baseline-[recurrence]-death). Only first-ever cases of AIS or ICH were included in the multistate analysis.
608 890 patients (mean age 64.29±13.72 years, 55.07% men) were hospitalised (370 527 AIS, 173 236 ICH and 65 127 undetermined pathology). There were 398 663 patients with first-ever AIS and ICH. Patients were followed up for a median (95% CI) of 4.47 years (4.45 to 4.49). HF was associated with an increase in postdischarge mortality in AIS (HR [99% CI] 1.69 [1.64 to 1.74]) and ICH (2.59 [2.07 to 3.26]). HF was not associated with AIS recurrence, while ICH recurrence was only significantly increased within the first 3 years after discharge (1.79 [1.18 to 2.73]).
HF increases the risk of mortality in both AIS and ICH. We are the first to report on high-risk periods of stroke recurrence in patients with HF with ICH. Specific targeted risk reduction strategies may have significant clinical impact for mortality and recurrence in stroke.
我们旨在研究心力衰竭(HF)对泰国一个全国性卒中队列的卒中死亡率(住院期间和出院后)及复发的影响。
我们使用了一个大型的基于保险的数据库,该数据库涵盖了2004年至2015年泰国公共卫生部门所有的卒中住院病例。分别采用逻辑回归和Royston-Parmar回归来量化HF对住院期间和长期结局的影响。所有模型均根据年龄、性别和合并症进行了调整,并按卒中类型分层:急性缺血性卒中(AIS)或脑出血(ICH)。使用灵活的生存技术构建多状态模型,以预测HF对卒中患者疾病进程(基线-[复发]-死亡)的影响。多状态分析仅纳入首次发生的AIS或ICH病例。
608890例患者(平均年龄64.29±13.72岁,男性占55.07%)住院(370527例AIS,173236例ICH,65127例病理未明确)。有398663例首次发生AIS和ICH的患者。患者的中位(95%CI)随访时间为4.47年(4.45至4.49年)。HF与AIS出院后死亡率增加相关(HR[99%CI]1.69[1.64至1.74]),与ICH出院后死亡率增加相关(2.59[2.07至3.26])。HF与AIS复发无关,而ICH复发仅在出院后的前3年内显著增加(1.79[1.18至2.73])。
HF增加了AIS和ICH的死亡风险。我们首次报告了HF合并ICH患者卒中复发的高危期。特定的针对性风险降低策略可能对卒中的死亡率和复发具有显著的临床影响。